Regulatory Information
HSA regulatory responsibility and product classification details
Regulatory Responsibility
Product Classification
Formulation Information
CREAM
**RECOMMENDED DOSAGE** : Wash and dry affected areas. Apply sparingly on the affected parts and surrounding skin areas twice daily, morning and evening. Regular applications are essential for successful treatment. Treatment should be continued for two weeks after all clinical signs have disappeared. Attention to hygiene is important in the management of fungal diseases, particularly of the folds and feet. If no improvement is seen after 4 weeks, diagnosis should be reviewed.
TOPICAL
Medical Information
**INDICATIONS** : Topical treatment of tinea pedis, tinea cruris, tinea corporis due to Trichophytes rubrum, Trichophyton mentagrophytes, Epidermophyton floccosum, and Microsporum canis; tinea versicolor due to Malassezia furfur; erythrasma, candidiasis due to Candida albicans including cutaneous candidiasis, paronychia, external genital candidiasis and candidal balanitis.
**CONTRAINDICATIONS** : Hypersensitivity to clotrimazole, or any component in the preparation.
D01AC01
clotrimazole
Manufacturer Information
ZUELLIG PHARMA PTE. LTD.
HOE PHARMACEUTICALS SDN BHD
Active Ingredients
Documents
Package Inserts
proposed PI_jun 2015.pdf
Approved: January 14, 2021